ZAK is providing services in the entire area of clinical research development in Europe. We are ready to share with you more than 20 years of experience in clinical research and regulatory affairs in order to ensure the success of your projects!
If you are looking for professional support, we will find solutions which meet your interest, budget and internal resources!
Jean-Jacques Chirikdjian, M.Sc. (pharm) Ph.D.
Chief Executive Officer
Ingrid Hochmayer, M.Sc.
Managing Director/International Head of Clinical Operations/Vendor Manager
Patrizia Kahl-Rainer, D.Sc.
International Group Leader/Senior Project Manager
Éva Ráczkevy, MD
Head of Hungarian Representation/Co-Managing Director
7 Reasons your Clinical Trial isn't recruiting enough patients
As many as 85% of clinical trials fail to recruit and retain enough patients in order to meet their enrollment timeline. In total, 80% of trials fail to finish on time, despite the fact that a good third of a study budget often goes into patient recruitment and retention. (1)
50% of sites enroll one or no patients in their study, meanwhile studies show that only 3% of cancer patients are even aware of opportunities to take part in a clinical trial. (2) Sponsors and clinical research organizations are finding it increasingly difficult to attract and retain the required number of patients for studies, which leads to a costlier clinical trial, lower staff morale and less statistical power for the study and the validity of the results. Here are 7 potential reasons why studies are not recruiting enough patients:
What do Future Doctors know about Clinical Trials?
Clinical trials are the backbone of modern medicine. Without clinical trials, we would not know the correct dosage to use, for which indications a drug works or what the side effects, contraindications and possible interactions are.
Due to many laws and regulations that have been implemented over the last century (Nuremberg Code, the Declaration of Helsinki, GCP) clinical trials have been developed to be as ethical and unbiased as possible.
Despite all this - what do Medical Doctors actually know about clinical trials and what exactly is taught at medical school?
Gemeinsames Mittagessen als Teil der Unternehmenskultur von ZAK
Montag Suppen- oder Kalte-Platte-Tag, Dienstag Nudeltag, Mittwoch Spaghetti-Tag, Donnerstag Fischtag… so oder so ähnlich geht es bei uns Woche für Woche in einer gewissen Regelmäßigkeit oder Vorhersehbarkeit betreffend Mittagessen her. Als Mitarbeiter von ZAK dürfen wir montags bis donnerstags eine frisch zubereitete und überwiegend warme Mahlzeit auf Firmenkosten konsumieren, ohne uns Gedanken ums Essen machen zu müssen.
Honour for ZAK CEO
On November 9th the golden badge of honour of the state of Vienna was awarded to our CEO for special efforts at the Viennese town hall. In the course of an official ceremony Dr. Jean-Jacques Chirikdjian has received the honour for his contribution as a researcher, developer and business owner.
Opportunities for Small/Medium Enterprises
Over the past decade, the rising costs of R&D combined with profit pressures, increased regulatory requirements, need for innovation in R&D process, resulted in changing of outsourcing strategy of all big pharmaceutical companies to strategic partnerships. The majority of companies indicated a preference to engage global CROs for exclusive partnerships rather than mid-sized or niche CROs.